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Abstract
Aim To illustrate the pre-hospital management arsenals and protocols in different EMS units, and to estimate the perceived
difficulty of diagnosing suspected acute heart failure (AHF) compared with other common pre-hospital conditions.
Methods and results A multinational survey included 104 emergency medical service (EMS) regions from 18 countries.
Diagnostic and therapeutic arsenals related to AHF management were reported for each type of EMS unit. The prevalence and
contents of management protocols for common medical conditions treated pre-hospitally was collected. The perceived difficulty
of diagnosing AHF and other medical conditions by emergency medical dispatchers and EMS personnel was interrogated.
Ultrasound devices and point-of-care testing were available in advanced life support and helicopter EMS units in fewer than 25%
of EMS regions. AHF protocols were present in 80.8% of regions. Protocols for ST-elevation myocardial infarction, chest pain, and
dyspnoea were present in 95.2, 80.8, and 76.0% of EMS regions, respectively. Protocolized diagnostic actions for AHF
management included 12-lead electrocardiogram (92.1% of regions), ultrasound examination (16.0%), and point-of-care testings
for troponin and BNP (6.0 and 3.5%). Therapeutic actions included supplementary oxygen (93.2%), non-invasive ventilation
(80.7%), intravenous furosemide, opiates, nitroglycerine (69.0, 68.6, and 57.0%), and intubation 71.5%. Diagnosing suspected
AHF was considered easy to moderate by EMS personnel and moderate to difficult by emergency medical dispatchers (without
significant differences between de novo and decompensated heart failure). In both settings, diagnosis of suspected AHF was
considered easier than pulmonary embolism and more difficult than ST-elevation myocardial infarction, asthma, and stroke.
Conclusions The prevalence of AHF protocols is rather high but the contents seem to vary. Difficulty of diagnosing suspected
AHF seems to be moderate compared with other pre-hospital conditions.
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Introduction
Acute heart failure (AHF) is a common medical condition
encountered in the emergency departments (ED) and
pre-hospital settings.1,2 From 11–53% of AHF patients arrive
to the ED by ambulance.3–5 While the prognosis of AHF
patients’ remains poor,6–9 the importance of early phase and
pre-hospital management by emergency medical services
(EMS) has been recently underlined.10–13
Traditionally, EMS units are categorized by their resources
for diagnosis and care and the level of personnel. Typically,
advanced life support (ALS) units have a physician, nurse, or
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paramedic aboard (depending on the country) with readiness
for intravenous (IV) line insertion and IV-medication adminis-
tration. Most helicopter EMS (HEMS) units also correspond to
this category. In contrast, basic life support (BLS) units are
usually resourced and staffed for less critical situations.
The routine AHF management includes 12-lead electrocar-
diogram (ECG) recording, vital sign monitoring, option for
treatment with supplementary oxygen, non-invasive ventila-
tion (NIV), and administration of IV diuretics and vasodila-
tors.11,12 However, the administration of pre-hospital
medication seems scarce.3,4,13,14 Moreover, earlier studies
suggest that it might be difficult for EMS personnel to differ-
entiate AHF from other underlying causes of dyspnoea14–17
especially when the diagnosis is based only on patient’s med-
ical history and clinical signs and symptoms.18,19
Illustrative data on the possibilities of EMS to treat and di-
agnose AHF in the pre-hospital setting in accordance with the
guidelines are scarce. Bearing in mind these gaps in current
knowledge, the present study was designed to investigate
the possibilities to diagnose and treat AHF in the pre-hospital
setting. We also assessed the prevalence of specific manage-
ment protocols for dyspnoeic conditions and the perceived
difficulty of diagnosing suspected AHF and other critical con-
ditions encountered in EMS.
Methods
The EMS-AHF study was based on a multinational survey. The
surveys were sent to persons in charge of an EMS region. These
regional EMS leaders were contacted by key national emer-
gency physicians who agreed to participate in the present
study. Data were collected between November 2017 and
February 2018 from 104 EMS regions in 18 countries. Fifteen
of these countries were European (Belgium, Czech Republic,
Denmark, Estonia, Finland, France, Germany, Italy, Lithuania,
Monaco, Norway, Poland, Slovenia, Spain, and Switzerland).
In addition, Canada, Singapore, and the United States were
included.
The collected data included information about the different
types of EMS units and the diagnostic and therapeutic arse-
nals on board; BLS, ALS, and HEMS units were assessed sepa-
rately. The availability of diagnostic tools was classified into
three categories: 0 = ‘not on board’, 1 = ‘in some ambu-
lances’, and 2 = ‘in all ambulances’. Likewise, availability of
the treatment options was classified as 0 = ‘not available’,
1 = ‘permission needed’, and 2 = ‘permanent standing order’.
In addition, data on the prevalence of specific pre-hospital
management protocols for AHF, dyspnoea, chest pain, and
ST-elevation myocardial infarction (STEMI) were collected.
The data included information about diagnostic and therapeu-
tic actions, which were again classified as 0 = ‘not on board’,
1 = ‘permission needed’, and 2 = ‘permanent standing order’.
For statistical analyses, we combined Categories 1 and 2 and
compared with Category 0. Finally, the perceived difficulty of
diagnosing suspected AHF (distinguishing between de novo
AHF and acute-decompensated heart failure [ADHF]) and
other common conditions encountered in EMS (stroke, acute
coronary syndrome in general, STEMI, asthma attack, pulmo-
nary embolism, and sepsis) were estimated and graded accord-
ing to a 5-grade scale: 1 = ‘very easy’, 2 = ‘easy’, 3 = ‘moderate’,
4 = ‘difficult’, and 5 = ‘very difficult’. Separated scores grading
difficulty of diagnosing suspected AHF by emergency medical
dispatchers (EMD) and by EMS personnel were collected.
The categorical variables are presented as absolute values
and percentages and compared by Fisher’s exact test. Per-
ceived difficulty is presented as a quantitative variable ranging
from 1 (minimal difficulty) to 5 (maximal difficulty), reported
as mean and standard deviation, and compared by Student’s
t-test. Statistical analysis was performed using SPPS Version
25 (IBM Corp., Armonk, NY, USA).
Results
The survey covered more than 20% of the respective
country’s population in 11 out of 18 countries (Singapore
100.0%, Monaco 97.5%, Spain 79.0%, Estonia 70.5%, Finland
66.2%, Switzerland 39.5%, Lithuania 29.4%, Norway 29.4%,
Belgium 27.4%, Denmark 22.7%, and France 21.1%). The pop-
ulation coverage ranged from 2.2–13.2% in Canada, Czech
Republic, Germany, Italy, Poland, Slovenia, and United states.
The capability of EMS personnel to run diagnostic tests
(Figure 1) or to provide therapeutic treatments (Figure 2)
potentially needed for managing AHF patient largely varied
according with the type of EMS unit. The diagnostic and
therapeutic arsenals were more commonly available in ALS
and HEMS units than in BLS units. However, the availability
of point-of-care testing (POCT) and ultrasound, even in the ALS
and HEMS units, was quite low (less than 25% EMS regions had
these). With respect to therapeutic arsenal, apart from supple-
mentary oxygen, AHF treatments were available in roughly
one-third, or less, of BLS units, whereas majority of ALS and
HEMS units had these treatment options. Main AHF medica-
tions (diuretics and nitroglycerine) were available in approxi-
mately half of ALS units as permanent standing order.
A specific protocol for pre-hospital AHF management was
present in 84 regions (80.8%). Prevalence of protocols for
chest pain (84 regions, 80.8%, P = 1.00) and dyspnoea (79
regions, 76.0%, P = 0.50) was similar to AHF protocols.
Whereas, the prevalence of STEMI protocols was significantly
higher than AHF protocols (99 regions, 95.2%, P < 0.001).
The contents of the different management protocols are
shown in Table 1. With respect to diagnostic actions, 12-lead
ECG was included in almost all AHF protocols, whereas
POCTs for BNP and troponin were included only in few
protocols and ultrasound in 14–16% of protocols. In general,
AHF management most commonly—in over 90% of AHF
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protocols—involved acquisition of 12-lead ECG, insertion of
an IV line, and administration of supplementary oxygen.
With respect to therapeutic actions, after supplementary
oxygen, NIV was the most common action (present in the
AHF protocols of 80.7% EMS regions), followed by intubation
(71.5%), IV diuretics (69%), IV opiates (68.6%), and IV nitroglyc-
erine (57.0%). Compared with the non-specific dyspnoea pro-
tocols, AHF protocols more frequently included IV diuretic
and nitroglycerine administration; compared with chest pain,
IV diuretics and NIV were more frequently recommended.
Figure 1 Availability of diagnostic tools in different type of emergency medical service units. HEMS, helicopter emergency medical services.
Figure 2 Possibility of administration of common therapeutic treatments for acute heart failure in different emergency medicine service units including
those with permanent standing order and those requiring permission. HEMS, helicopter emergency medical services; IV, intravenous.
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Compared with STEMI protocols, AHF protocols less frequently
included ECG and IV opiate administration, and more fre-
quently IV diuretic and NIV use (Table 1).
Surveys about the perceived difficulty of diagnosing
suspected AHF by EMS personnel and by EMD were provided
by 101 (97.1%) and 96 (92.3%) participants, respectively. They
did not report significant differences between diagnostic diffi-
culty of de novo AHF and ADHF in either scenario. De novo
AHF and ADHF were both graded to be easy to moderate to
suspect by EMS personnel and moderate to difficult by EMD
(Figure 3). For EMD, both types of AHF were significantly more
difficult to suspect than stroke and acute asthma and easier
than pulmonary embolism. On the other hand, for EMS per-
sonnel, AHF (de novo and ADHF) was significantly more diffi-
cult to suspect than STEMI, stroke, and acute asthma and
easier than pulmonary embolism (Figure 3). For all the condi-
tions assessed, suspicion by EMD was always considered to
be significantly more difficult than by EMS personnel.
Discussion
The EMS-AHF study describes for the first time the pre-hospital
management of AHF from a multinational perspective. Our
study provides three main findings. First, though only minority
of EMS units carry diagnostic tools that can help in AHF diagno-
sis, the majority of units have the possibility to provide recom-
mended AHF treatments. Second, AHF management protocols
are common in the pre-hospital setting. Yet, the contents of
these protocols vary between EMS regions. Third, diagnosing
suspected AHF is perceived to be easy to moderate at scene
but moderate to difficult at dispatching centres, with no signif-
icant difference reported between ADHF and de novo AHF.
The differential diagnosis between AHF and other medical
conditions causing dyspnoea is difficult without the use of
diagnostic tools20 and may lead to misdiagnosis and inappro-
priate, even harmful, treatment of dyspnoeic patients.1 Our
survey showed that the prevalence of diagnostic tools is low
in the EMS units, even in ALS and HEMS units. Thus, there is
room for improvement in the availability of diagnostic tools,
such as POCTs for BNP and troponin and ultrasound devices
in the EMS units’ arsenals.
The availability of therapeutic arsenals varies between
different types of EMS units, as could be expected from their
roles in the EMS organization. IV diuretics and vasodilators such
as nitroglycerine (the mainstay of AHF treatment)21 are on
board in the majority of ALS and HEMS units, whereas only a
minority of BLS units can provide these treatments. Very recent
data suggest that early IV diuretic administration may improve
mortality in AHF.9–12 Considering these two findings, it is
important that EMD provides the most appropriate EMS unit
for a patient with suspected AHF. However, the reported
proportion of AHF patients calling to dispatching centres varies
from 11% in Finland 3 to 53% of cases in Spain,4 and less than
one-third of AHF patients are managed by an ALS unit.3,4 The
SEMICA study (Emergency Medical Response Systems for
Patients with Acute Heart Failure) explored factors associated
with EMS unit provision by EMD and found out that ALS unit
assignment was well related to the severity of AHF.4,22
In our survey, most of the EMS regions had a specific man-
agement protocol for AHF. The prevalence of AHF protocols
was similar to that of chest pain and dyspnoea protocols.
Some earlier studies show that delays in AHF management
may increase mortality and morbidity.19,23 The use of specific
management protocols in EMS might reduce the delays in the
initiation of pre-hospital management. The prevalence of AHF
Table 1 Protocolized actions contained in the acute heart failure management protocol and in the other three additional pre-hospital
protocols surveyed
AHF Dyspnoea Chest pain STEMI
N = 84 N = 79 N = 84 N = 99
Diagnostic actions
Total % (% permission request needed/% permanent standing order)
Take a 12-lead ECG 92.1 (20.5/71.6) *** 84.5 (20.2/64.3) 98.8 (21.8/77.0) 99.0 (19.0/80.0)
Run a POC-testing for troponin 6.0 (2.4/3.6) 7.2 (3.6/3.6) 8.2 (3.5/4.7) 8.2 (1.0/7.2)
Run a POC-testing for BNP/NT-proBNP 3.5 (3.5/0.0) 3.6 (3.6/0.0) 3.5 (3.5/0.0) 2.1 (0.0/2.1)
Do ultrasound 16.0 (5.7/10.3) 15.5 (6.0/9.5) 14.9 (5.7/9.2) 15.0 (4.0/11.0)
Therapeutic actions
Total % (% permission request needed/% permanent standing order)
Insert an IV line 94.3 (21.6/72.7) 90.4 (21.4/69.0) 95.4 (21.8/73.6) 98.0 (20.2/77.8)
Provide supplementary oxygen 93.2 (21.6/71.6) 92.8 (23.8/69.0) 86.2 (17.2/69.0) 87.0 (24.0/63.0)
Provide IV diuretics 69.0(29.9/39.1)*, **, *** 49.4 (24.1/25.3) 32.6 (14.0/18.6) 36.4 (17.2/19.2)
Provide morphine or another opiate 68.6 (22.1/46.5)*** 54.9 (19.5/35.4) 80.0 (25.9/54.1) 89.8 (29.6/60.2)
Provide IV nitroglycerine 57.0 (31.4/25.6)* 31.4 (16.9/14.5) 50.6 (18.8/31.8) 60.2 (24.5/35.7)
Provide non-invasive ventilation 80.7(25.0/55.7)**, *** 82.2 (28.6/53.6) 45.4 (16.3/29.1) 50.5 (22.8/27.7)
Perform intubation 71.5 (29.5/42.0) 77.3 (33.3/44.0) 64.3 (24.1/40.2) 65.0 (27.0/38.0)
AHF, acute heart failure; BNP, brain natriuretic peptide; ECG, electrocardiogram; IV, intravenous; NT-proBNP, N terminal pro brain
natriuretic peptide; POC, point of care; STEMI, ST-elevation myocardial infarction.
*P < 0.05 in comparison with the dyspnea protocol.
**P < 0.05 in comparison with the chest pain protocol.
***P < 0.05 in comparison with the STEMI protocol.
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management protocols can be considered rather high as the
early diagnosis and treatment of AHF have been emphasized
somewhat recently.11–13 As expected, management protocols
for STEMI were even more prevalent because of stronger evi-
dence and recommendation in guidelines.24 The importance
of time to treatment in STEMI is unambiguous, as the condi-
tion evolves more abruptly compared with AHF. In contrast,
the prognostic significance of time to treatment in AHF still re-
mains controversial.10,25 More importantly, AHF manifests in
several clinical phenotypes, which vary in their acuity and se-
verity.26 Specific causes of AHF like acute coronary syndrome,
hypertensive emergency, or arrhythmias justify cause-specific
pre-hospital management as well. Interestingly, chest pain
protocols were no more common than AHF protocols, and
dyspnoea protocols were reported only in 76% of EMS regions.
The contents of the management protocols vary between
the EMS regions. The prevalence of IV opiates was high in
the AHF management protocols, which is somewhat alarming
because opiates are not a routine medication for all AHF pa-
tients and is recommended to be used with caution.21,27
Moreover, IV opiates were included in AHF management pro-
tocols more often than IV nitroglycerine, which in contrast is
one of the mainstay medications well available in EMS units.
A vast majority of AHF protocols included respiratory support,
which is an essential part of AHF management, and timely NIV
may reduce the need for intubation in pulmonary oedema.28
The diagnosis of both de novo AHF and ADHF is perceived
to be easy to moderate. It was found to be significantly more
difficult in the dispatching centres. In comparison, STEMI was
considered the easiest pre-hospital condition to diagnose
among all the conditions surveyed, probably because of the
rather unequivocal diagnostic ECG criteria based on ST
changes and the high availability of 12-lead ECG. In the case
of AHF, the POCT for BNP could play a similar role.
Further studies should be done to evaluate the accuracy of
the pre-hospital AHF diagnosis.
Limitations
There are some limitations to be acknowledged. First, the na-
tional representativeness of the surveys in different countries
was variable. Still, we feel that our survey gives an adequate
overview of the current status. Second, the diagnostic diffi-
culty in the pre-hospital setting was based on subjective views
of the EMS regional leaders. However, the interview of individ-
ual staff members was beyond the scope of the present study.
Conclusions
The prevalence of AHF protocols is rather high and, AHF-
treatment options, especially respiratory support, are readily
Figure 3 Perceived difficulty of diagnosing suspected acute heart failure (differentiated by de novo and decompensated) by emergency centre
dispatchers (blue) and by emergency medical service personnel at scene (red). Comparisons were established between pairs in the same setting.
*P < 0.05 compared with de novo acute heart failure. **P < 0.05 compared with acutely decompensated heart failure.
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available in ALS and HEMS units. The pre-hospital diagnosis of
critical medical conditions is perceived to be significantly more
difficult in dispatching centre compared with the EMS at scene.
The diagnosis of both ADHF and de novo AHF is reported to be
easy, even though the prevalence of diagnostic tools in EMS
units is scarce. Future studies are warranted to investigate
the accuracy of the EMS diagnosis and the cause behind the
perceived diagnostic easiness of AHF.
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